Follow the 康泰医学 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 康泰医学 has published 29 public disclosures. Market capitalisation: €4.1bn. The latest transaction was reported on 14 November 2025 (Sale). Among the most active insiders: 胡坤. Every trade is openly available.
29
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€29m
29 ops.
Sell Volume
22Σ signal
Buys n/a€29m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,768 of 28,985 companies
34.5
score / 100
Value
33
Quality
36
FCF yld-0.7%
Earn yld-0.6%
EV/EBITDA·
ROE-2.7%
Gross mgn48%
Net mgn-5.2%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
